The U.S.
Author: Michael
Collagevita’s Medical Director explains why re
Pemvidutide’s balanced glucagon/GLP-1 action h
EHE Health’s partnership with Prenuvo brings b
Niagen Bioscience announced that Tru Niagen is no
Fractyl Health will host a virtual Commercial Str
Mitochon Pharmaceuticals has been awarded a $1 mi
Phase 2a study completes enrollment as biotech t
Corundum Corp’s Maayan Eilon-Ashkenazy explain
FDA accelerates development of XellSmart’s off